Coherus Biosciences reported $408.28M in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Aerie Pharmaceuticals AERI:US $ 234.53M 6.34M
Ironwood Pharmaceuticals IRWD:US $ 515.63M 61.44M
Myriad Genetics MYGN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 23.04B 703M
Zoetis ZTS:US $ 6592M 0M